Enterprise Bank & Trust CO Biogen Inc. Transaction History
Enterprise Bank & Trust CO
- $264 Million
- Q2 2025
A detailed history of Enterprise Bank & Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Enterprise Bank & Trust CO holds 2,618 shares of BIIB stock, worth $378,798. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,618
Previous 2,663
1.69%
Holding current value
$378,798
Previous $364,000
9.89%
% of portfolio
0.12%
Previous 0.14%
Shares
13 transactions
Others Institutions Holding BIIB
# of Institutions
1,024Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.5 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.29 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.1 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.08 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$694 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...